Skip to main content

Sezaby FDA Approval History

Last updated by Judith Stewart, BPharm on Nov 30, 2022.

FDA Approved: Yes (First approved November 17, 2022)
Brand name: Sezaby
Generic name: phenobarbital sodium
Dosage form: Powder for Injection
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Neonatal Seizures

Sezaby (phenobarbital sodium) is a barbiturate indicated for the treatment of neonatal seizures in term and preterm infants.

Development timeline for Sezaby

Nov 18, 2022Approval FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.